A record number of U.S.-based marijuana companies are turning to Canada to fund aggressive expansion in the United States and globally. The companies, which face investment constraints in the United States, are being lured by Canada’s cannabis-friendly capital markets and a growing appetite among international investors for American MJ assets. So far this year, 17 […]
Read MoreMedMen
MedMen inks CA$75M equity financing deal to expand US cannabis operations
Los Angeles-based MedMen Enterprises says it expects to raise up to 75 million Canadian dollars ($57 million) in a bought-deal equity financing plan, with the proceeds to be used to expand its U.S. retail footprint. Here’s a rundown of the deal: Toronto-based Eight Capital and Cormark Securities – as co-lead underwriters and joint bookrunners – […]
Read MoreWeek in Review: New Ohio processing licenses, CA marijuana black market & Florida judge nixes MMJ business cap
Ohio awards provisional medical marijuana processing licenses, a cannabis consumer survey in California confirms licensed MJ businesses are losing market share to illicit operators, and a Florida judge says a state law restricting the number of MMJ businesses runs afoul of a voter-approved constitutional amendment. Here’s a closer look at some notable developments in the […]
Read MoreBig hits: Cannabis companies on pace to raise record $8 billion in 2018
Marijuana companies across the globe are on pace to raise a record $8 billion by the end of 2018 as more companies go public and scale to meet growing demand, an analysis of recently released market data shows. Through the end of June, cannabis companies raised a record $4.3 billion – more than triple the […]
Read MoreOntario’s cannabis pivot could create massive retail opportunities
A week after it was reported that Ontario froze leasing efforts for its monopoly cannabis retail chain, Canada’s largest province appears to be on the verge of handing adult-use marijuana sales entirely to the private sector. The news, first reported by Cannabis Compliance Vice President Deepak Anand and then in The Globe and Mail, would reverse the […]
Read MoreMarijuana M&A activity spikes as some cannabis pioneers cash out
Merger and acquisition activity is accelerating across the cannabis industry as more companies land multimillion-dollar capital infusions and ink deals aimed at growing market share. The momentum is giving more company founders an opportunity to cash out at an attractive price – or leverage the deals to launch their next venture. The flurry of activity […]
Read MoreCannabis firm 4Front to go public after closing $13.4 million raise
Arizona-based 4Front Holdings is charting a path to go public in Canada following its latest $13.4 million funding round.
Read MoreCorporate governance: 5 steps marijuana firms should take as they grow
Rapid growth across the cannabis industry is forcing thousands of firms to grow up fast – and it’s not always a smooth process. As companies hustle to gain market share and raise capital in an increasingly competitive environment, many are still playing catch up on basic corporate governance controls.
Read MoreUS marijuana company Green Thumb Industries makes trading debut in Canada
Green Thumb Industries has joined the ranks of a growing list of cannabis firms to go public in Canada’s booming marijuana market, debuting on the Canadian Securities Exchange under the ticker symbol GTII. Increasingly, U.S. marijuana companies are turning to Canada’s public markets to tap easier-to-access capital.
Read MoreMedMen inks $53 million acquisition of Florida cannabis cultivator, dispensary sites
MedMen Enterprises has signed a deal to acquire a Florida-based cultivator and the right to open up to more than two dozen dispensaries across the state. The $53 million deal catapults MedMen into Florida’s growing medical marijuana market – a state expected to hit $1 billion in sales by 2020.
Read MoreFive reasons why lighting giant Osram’s acquisition of Fluence is a big deal for cannabis
One of the cannabis industry’s largest lighting solutions suppliers, Austin, Texas-based Fluence Bioengineering was recently acquired by Osram, a $4.1 billion firm based in Munich, Germany. The deal may signal increased interest from international firms and investors on the hunt for ancillary cannabis companies.
Read MoreWhat cannabis investors should know about MedMen’s Canadian trading debut
Los Angeles-based MedMen is the latest U.S. cannabis company to go public in Canada as more firms hustle to raise the capital needed to stay ahead in the green rush.The multistate marijuana firm debuted Tuesday on the Canadian Securities Exchange under the ticker MMEN.
Read More